AMENDMENT AGREEMENT As of March 30, 2011Amendment Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
This Amendment Agreement (this “Agreement”) is entered into by and among IASO Pharma Inc. (f/k/a Pacific Beach Biosciences, Inc.), a Delaware corporation (the “Company”), and Capretti Grandi, LLC (“Holder”).
AMENDMENT AGREEMENT As of March 30, 2011Amendment Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
This Amendment Agreement (this “Agreement”) is entered into by and among IASO Pharma Inc. (f/k/a Pacific Beach Biosciences, Inc.), a Delaware corporation (the “Company”), and each holder of 2007 Notes (as such term is defined below) listed on the signature pages hereto (together with successors and assigns of each, a “Holder,” and collectively, the “Holders”), and solely with respect to Section 3 of this Agreement, Lindsay A. Rosenwald, M.D.
SUBSCRIPTION AGREEMENTSubscription Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
THIS SUBSCRIPTION AGREEMENT (this “Agreement”) is made by and among IASO Pharma Inc., a Delaware corporation (the “Company”), Wells Fargo Bank, National Association, not in its individual capacity but solely as collateral agent (“Agent”), Manchester Securities Corp. and Lindsay A. Rosenwald, M.D. (each, a “Subscriber” and together, the “Subscribers”). The Subscribers are also sometimes referred to herein together as the “Backstop Investors”.
AMENDMENT No. 3 to LICENSE AGREEMENTLicense Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations
Amendment No. 3 made and effective as of March 23, 2011 to the License Agreement dated June 12, 2007 entered into by and between IASO Pharma Inc. (formerly Pacific Beach Biosciences, Inc.), a Delaware corporation having a place of business at 12707 High Bluff Drive, Suite 200, San Diego, CA 92130 (“Company”) and Dong Wha Pharm. Co. Ltd., a Korean corporation having a place of business at 5 Soonwha-dong, Joong-ku, Seoul 100-130, Korea (“Licensor”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • Delaware
This STOCK REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 27, 2011 (the “Effective Date”), by and between IASO Pharma Inc., a Delaware corporation, with offices at 12707 High Bluff Drive, Suite 200, San Diego, California 92130 (the “Company ”) and __________________, [a/an] _________ [residing/having an address] at ____________________ (the “Selling Stockholder”).
AMENDMENT AGREEMENT As of March 30, 2011Amendment Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
This Amendment Agreement (this “Agreement”) is entered into by and between IASO Pharma Inc., a Delaware corporation (the “Company”), and Timothy Hofer (“Holder”) and amends the warrant to purchase shares of the Company’s common stock, dated as of May 16, 2010, as amended as of September 16, 2010 and December 22, 2010, issued by the Company to Holder (the “Warrant”).
AMENDMENT AGREEMENT As of June 10, 2011Amendment Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
This Amendment Agreement (this “Agreement”) is entered into by and among IASO Pharma Inc., a Delaware corporation (the “Company”), and each holder of Rights Offering Notes (as such term is defined below) listed on the signature pages hereto (together with successors and assigns of each, a “Holder,” and collectively, the “Holders”).
BACKSTOP COMMITMENT AGREEMENTBackstop Commitment Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
THIS BACKSTOP COMMITMENT AGREEMENT (this “Agreement”), dated as of April 6, 2011, is by and among IASO Pharma Inc., a Delaware corporation (the “Company”), and Manchester Securities Corp., a New York corporation (“Manchester”), and Lindsay A. Rosenwald, M.D. (“Rosenwald”). Each of Manchester and Rosenwald is referred to herein as a “Backstop Investor”).
SECURITY AGREEMENTSecurity Agreement • June 24th, 2011 • Iaso Pharma Inc • Pharmaceutical preparations • New York
This SECURITY AGREEMENT (this “Agreement”), dated as of April 29, 2011, is made by and between IASO Pharma Inc. (the “Grantor”), and Wells Fargo Bank, National Association, a national banking association, as collateral agent for the Secured Parties (as defined herein) (the “Agent”).
